Mesoblast | MSB - Nettoeinkommen

Aktienkurs
2.04
Täglich Wechseln
-0.03 -1.21%
Monatlich
-0.73%
Jährlich
19.71%
Q2 Prognose
2.08




Nettoeinkommen Veränderung Datum
Avita Medical AUD -11.62M 1.7M 2025-12
Clinuvel Pharmaceuticals AUD 10.44M 11.65M 2025-12
Cochlear AUD 161.5M 69.6M 2025-12
CSL USD 401M 96.5M 2025-12
Pacific Edge NZD -19.12M 3.68M 2025-12
Paradigm Biopharmaceuticals AUD -23.24M 16.82M 2025-12
PYC Therapeutics AUD -22.83M 10.46M 2025-12
Ramsay Health Care AUD 152.7M 32.4M 2025-12
Sonic Healthcare AUD 236.68M 82.29M 2024-12
Starpharma Holdings AUD 1.37M 3.67M 2025-12
Telix Pharmaceuticals AUD -4.83M 2.54M 2025-12